ELOS B — Elos Medtech AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.64bn
- SEK1.52bn
- SEK888.54m
- 82
- 28
- 21
- 37
Annual cashflow statement for Elos Medtech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.5 | 50.6 | 43.3 | 98 | 99.1 |
| Depreciation | |||||
| Non-Cash Items | 2.82 | 3.68 | 11.3 | -2.09 | 8.59 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -21.7 | -12.1 | 11 | -46.4 | -66.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 66 | 102 | 126 | 105 | 108 |
| Capital Expenditures | -79.9 | -98.6 | -56.5 | -85.6 | -117 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 1.25 | 0.245 | 0.122 | 0 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -79.9 | -97.3 | -56.3 | -85.4 | -117 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 53.1 | 0.914 | -31.3 | -19 | 74 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 39.3 | 6.21 | 33.3 | 6.68 | 73.6 |